Medical Engineering News
-
Field Orthopaedics Announces Plans to Debut Award-Winning Micro Screw at AAOS in Las Vegas
Field Orthopaedics, a rapidly growing Australian orthopaedic devices company that focuses on the design and manufacturing of orthopaedic devices to address the shortcomings in the trauma, extremities and biological markets, today announced plans to showcase its FIELD MICRO SCREW SYSTEM at the 2019 American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas on March 12- ...
-
ApiLabs, R&D sister company to ApiJect, launches its Field Research Network
ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare access for patients in all world regions, has launched its ApiLabs Field Research Network (AFRN). AFRN gathers qualitative and quantitative data from real-world settings through ground level investigations, particularly in low- and middle-income countries. Resulting information helps ApiLabs ...
-
Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for its Series A round with new and existing investors. The investment was co-led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, ...
-
NuShores welcomes a new Quality and Regulatory medical device professional to Little Rock
Little Rock, AR – NuShores Biosciences LLC (NuShores), founded and based in Little Rock, Arkansas, announced today that Mr. Sam Monk has accepted the position of Regulatory and Quality Manager and will move to Little Rock from the Seattle area. Mr. Monk will work closely with C-level management, research scientists, manufacturing, and our Quality and Regulatory team and services providers ...
-
Intin, a Digital Healthcare Startup, Honored With the `CES Innovation Award` for Technological Prowess in Healthcare
The COVID-19 pandemic has brought healthcare to the forefront for the global community. Companies and businesses bringing in innovation in healthcare and developing digital healthcare platforms are sought after. Korean company Intin Inc. (https://intin.kr/en/) has been recently honored with the 'Innovation Award' from CES (Consumer Electronics Show) for its 'Oview Multi Device' product, a ...
By INTIN Inc.
-
Eyevensys Enters Collaboration with Phillips-Medisize and Minnetronix Medical
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announces it has entered into strategic engagements with US-based medical device manufacturers Phillips-Medisize and Minnetronix Medical to develop the next generation of the company’s core technology. Eyevensys has developed a non-viral gene therapy ocular ...
By Eyevensys
-
Berlin Heart Received CE Mark and Announces First Implantation of the Latest Cannula Generation to Treat Heart Patients Waiting for a Donor Heart
Berlin, September 2021: Berlin Heart today announces the CE mark and first implantation of an innovative outflow cannula for mechanical circulatory support with the paracorporeal pulsatile EXCOR® ventricular assist device. The EXCOR® Graft Cannula* connects the outflow side of the blood pump to the ascending aorta for left ventricular support or to the pulmonary artery for right ...
-
Sherlock Biosciences Announces Appointment of Bryan Dechairo as President and Chief Executive Officer
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that Bryan Dechairo, Ph.D. has been appointed president and chief executive officer. He will also join Sherlock’s board of directors. He succeeds Co-Founder Rahul Dhanda, who will continue to serve as a board member until the end of 2021 and then as ...
-
Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up to 10 Million Tests Per Month
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that its partnerships will increase COVID-19 diagnostic manufacturing capacity by up to 10 million tests per month by year-end. Through multiple license agreements this year with organizations including ALBOT ...
-
The 221b Foundation Grants License to ALBOT Technologies to Develop, Manufacture and Distribute CRISPR COVID-19 Diagnostic Kits in India
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted a license to ALBOT USA and ALBOT Technologies Private Limited India to develop, manufacture and distribute COVID-19 diagnostic tests using Sherlock’s CRISPR technology. ALBOT has current ...
-
Sherlock Biosciences Announces Initial Results of Automation Study with NorDx Laboratories on CRISPR-based Test for SARS-CoV-2
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced initial results from an automation study of its CRISPR-based test for SARS-CoV-2 in partnership with NorDx Laboratories, a member of MaineHealth – a recognized leader in New England and Maine’s largest integrated healthcare system. The study ...
-
Lubron are Exhibiting at Healthcare Estates
At Lubron UK, we understand the unique requirements of the healthcare sector and the need for durability and reliability in our products and medical water treatment services. We have a first-class reputation for providing fully HTM and BS EN ISO15883 compliant water treatment systems for sterile services, clinical decontamination, pathology laboratories and endoscopy departments. But it ...
-
Sherlock Biosciences’ CRISPR SARS-Cov-2 Test Selected As Finalist In “On The Rise” And Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards
From a cleaner freight train to an automated beehive, a way to recycle fabric, and other bold, new technologies, the 5th annual awards honor the products, concepts, companies, policies, and designs that are pursuing innovation for the good of society and the planet. Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, has ...
-
The 221b Foundation and LogicInk Announce License Agreement to Utilize Sherlock Biosciences’ CRISPR Technology to Develop Instrument-free Diagnostic for COVID-19
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, and LogicInk, a lifestyle sensor company developing bio-chemical Signals that can be worn or applied daily, today announced the organizations have entered into a license agreement to enable LogicInk to utilize Sherlock ...
-
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain's recent strategic transition into the healthcare and in-vitro diagnostics space. ...
-
MediPines AGM100 Voted as Finalist in Medical Design Excellence Awards, MDEA 2021
We are pleased to announce that MediPines AGM100, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards (MDEA). The MDEAs is the premier design competition in the MedTech industry organized by MD+DI and recognizes the significant achievements in medical product design and engineering that improve the quality of healthcare delivery ...
By MediPines
-
The 221b Foundation Grants Licenses to Multiple Organizations to Develop and Distribute CRISPR COVID-19 Diagnostic Kits Globally
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted Cooper International and United PPE licenses to develop and manufacture COVID-19 diagnostic tests using Sherlock’s CRISPR technology. The agreements will increase access in Asia and the ...
-
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the American Institute for Biological and Medical Engineering (AIMBE) has elected Murthy Simhambhatla, PhD, to the AIMBE College of Fellows for “outstanding contributions as a medical technology innovator and business leader, advancing health for ...
-
Puzzle Medical announces partnership with strong leader in device development Sterling Medical
We are thrilled to announce our partnership with Sterling Medical Devices, a fully staffed U.S. based medical device engineering firm, to develop a lightweight portable controller that will be used with Puzzle Medical Devices Inc.’s ModulHeart. For over 20 years, Sterling has been dedicated to work with their clients’ medical device design and engineering developments, including ...
-
Sherlock Biosciences Receives $5 Million Grant to Advance INSPECTR™ Platform for COVID-19 Self-test
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced it has received a grant from the Bill & Melinda Gates Foundation in the amount of $5 million to continue to advance INSPECTRTM, its instrument-free, synthetic biology-based molecular diagnostics platform. “We are deeply grateful for the support ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you